Silvia Paola Caminiti
Silvia Paola Caminiti
Postdoc Fellow San Raffaele University, Milan
Email verificata su hsr.it
Titolo
Citata da
Citata da
Anno
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting
D Perani, C Cerami, SP Caminiti, R Santangelo, E Coppi, L Ferrari, ...
European journal of nuclear medicine and molecular imaging 43 (3), 499-508, 2016
452016
Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
SP Caminiti, L Presotto, D Baroncini, V Garibotto, RM Moresco, L Gianolli, ...
NeuroImage: Clinical 14, 734-740, 2017
332017
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
SP Caminiti, T Ballarini, A Sala, C Cerami, L Presotto, R Santangelo, ...
NeuroImage: Clinical 18, 167-177, 2018
282018
Metabolic connectomics targeting brain pathology in dementia with Lewy bodies
SP Caminiti, M Tettamanti, A Sala, L Presotto, S Iannaccone, SF Cappa, ...
Journal of Cerebral Blood Flow & Metabolism 37 (4), 1311-1325, 2017
282017
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease
A Pilotto, E Premi, SP Caminiti, L Presotto, R Turrone, A Alberici, ...
Neurology 90 (12), e1029-e1037, 2018
242018
Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease
A Sala, SP Caminiti, L Presotto, E Premi, A Pilotto, R Turrone, ...
Scientific reports 7 (1), 1-12, 2017
232017
Affective mentalizing and brain activity at rest in the behavioral variant of frontotemporal dementia
SP Caminiti, N Canessa, C Cerami, A Dodich, C Crespi, S Iannaccone, ...
NeuroImage: Clinical 9, 484-497, 2015
212015
Evaluation of an optimized [18F]fluoro‐deoxy‐glucose positron emission tomography voxel‐wise method to early support differential diagnosis in atypicalá…
SP Caminiti, P Alongi, L Majno, MA VolontŔ, C Cerami, L Gianolli, G Comi, ...
European journal of neurology 24 (5), 687-e26, 2017
192017
The emerging role of PET imaging in dementia
L Iaccarino, A Sala, SP Caminiti, D Perani
F1000Research 6, 2017
172017
Validation of 18F–FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners
L Presotto, T Ballarini, SP Caminiti, V Bettinardi, L Gianolli, D Perani
Neuroinformatics 15 (2), 151-163, 2017
132017
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
SP Caminiti, A Sala, L Iaccarino, L Beretta, A Pilotto, L Gianolli, ...
Alzheimer's research & therapy 11 (1), 20, 2019
112019
The neural correlates of spatial and object working memory in elderly and Parkinson’s disease subjects
SP Caminiti, C Siri, L Guidi, A Antonini, D Perani
Behavioural neurology 2015, 2015
102015
Disease-related patterns of in vivo pathology in Corticobasal syndrome
F Niccolini, H Wilson, S Hirschbichler, T Yousaf, G Pagano, A Whittington, ...
European journal of nuclear medicine and molecular imaging 45 (13), 2413-2425, 2018
82018
The brain metabolic signature of visual hallucinations in dementia with Lewy bodies
L Iaccarino, A Sala, SP Caminiti, R Santangelo, S Iannaccone, G Magnani, ...
Cortex 108, 13-24, 2018
62018
Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation
V Castelnovo, SP Caminiti, N Riva, G Magnani, V Silani, D Perani
Neurological Sciences 40 (3), 515-521, 2019
52019
Vulnerability of multiple large‐scale brain networks in dementia with Lewy bodies
A Sala, SP Caminiti, L Iaccarino, L Beretta, S Iannaccone, G Magnani, ...
Human brain mapping 40 (15), 4537-4550, 2019
22019
Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD
L Beretta, SP Caminiti, R Santangelo, G Magnani, F Ferrari-Pellegrini, ...
Neuropsychologia 133, 107174, 2019
22019
In vivo signatures of neurodegeneration in isolated rapid eye movement behaviour disorder
G Carli, SP Caminiti, A Galbiati, S Marelli, F Casoni, A Padovani, ...
European Journal of Neurology, 2020
2020
Arterial spin labelling detects subcortical hypoperfusion in early drug-na´ve patients with Parkinson's disease: 1861
S Caminiti, G Pagano, G Dervenoulas, T Yousaf, H Wilson, M Politis
Movement Disorders 34, 2019
2019
Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson's Disease: pilot PET data: 1947
G Pagano, H Wilson, A Mansur, S Caminiti, R Comley, H Tsukada, ...
Movement Disorders 34, 2019
2019
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20